You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 15, April 19, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Development and Early Natural History of HTLV-III Antibodies in Persons With Hemophilia

M. Elaine Eyster, MD; James J. Goedert, MD; M. G. Sarngadharan, PhD; Stanley H. Weiss, MD; Robert C. Gallo, MD; William A. Blattner, MD

JAMA. 1985;253(15):2219-2223.


Abstract

Antibodies to human T-cell lymphotropic virus type III (HTLV-III) were first detected in 1979 in serum samples from 30 known seropositive patients with hemophilia, over half of whom seroconverted in 1981-1982. Lymphadenopathy was present in 70% who were seropositive more than three years, compared with 10% who were seropositive three years or less. T-helper cell counts were low (307 ± 64 cells/cu mm) in the early seroconverters, and normal in the late seroconverters. T-suppressor cell counts were not related to the year of seroconversion. The long latency period after seroconversion suggests an ongoing indolent process, rather than an acute infection. It remains to be determined whether this is an aberrant part of the immune response initiated by HTLV-III antigens or the result of a chronic active HTLV-III infection.

(JAMA 1985;253:2219-2223)



Author Affiliations

From the Division of Hematology, The Milton S. Hershey Medical Center of the Pennsylvania State University, Hershey (Dr Eyster); the Environmental Epidemiology Branch (Drs Goedert, Weiss, and Blattner) and the Laboratory of Tumor Cell Biology (Dr Gallo), National Cancer Institute, Bethesda, Md; and the Department of Cell Biology, Litton Bionetics Inc, Kensington, Md (Dr Sarngadharan).


Footnotes

Reprint requests to The Milton S. Hershey Medical Center, PO Box 850, Hershey, PA 17033 (Dr Eyster).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Splenectomy on Slowing Human Immunodeficiency Virus Disease Progression
Tsoukas et al.
Arch Surg 1998;133:25-31.
ABSTRACT | FULL TEXT  

Hemophilia A
Hoyer
NEJM 1994;330:38-47.
FULL TEXT  

Heterosexual Co-transmission of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)
Eyster et al.
ANN INTERN MED 1991;115:764-768.
ABSTRACT  

Predictive Markers for the Acquired Immunodeficiency Syndrome (AIDS) in Hemophiliacs: Persistence of p24 Antigen and Low T4 Cell Count
Eyster et al.
ANN INTERN MED 1989;110:963-969.
ABSTRACT  

Tendency to Serious Sequelae of Infection With the Human Immunodeficiency Virus in Sibships With Hemophilia
Meropol et al.
Arch Intern Med 1989;149:885-888.
ABSTRACT  

Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men
Jason et al.
JAMA 1989;261:725-727.
ABSTRACT  

Human Immunodeficiency Virus Isolation Studies and Antibody Testing: Household Contacts and Sexual Partners of Persons With Hemophilia
Brettler et al.
Arch Intern Med 1988;148:1299-1301.
ABSTRACT  

Natural History of Human Immunodeficiency Virus Infections in Hemophiliacs: Effects of T-Cell Subsets, Platelet Counts, and Age
EYSTER et al.
ANN INTERN MED 1987;107:1-6.
ABSTRACT  

Clinical, Immunologic, and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome: The San Francisco Men's Health Study
Lang et al.
JAMA 1987;257:326-330.
ABSTRACT  

Effect of T4 Count and Cofactors on the Incidence of AIDS in Homosexual Men Infected With Human Immunodeficiency Virus
Goedert et al.
JAMA 1987;257:331-334.
ABSTRACT  

Human T-Cell Lymphotropic Virus Type III Infection in a Cohort of Homosexual Men in New York City
Stevens et al.
JAMA 1986;255:2167-2172.
ABSTRACT  

Long-Term Seropositivity for Human T-Lymphotropic Virus Type III in Homosexual Men Without the Acquired Immunodeficiency Syndrome: Development of Immunologic and Clinical Abnormalities: A Longitudinal Study
MELBYE et al.
ANN INTERN MED 1986;104:496-500.
ABSTRACT  

Epidemiology of Human T-Lymphotropic Virus Type III and the Risk of the Acquired Immunodeficiency Syndrome
BLATTNER et al.
ANN INTERN MED 1985;103:665-670.
ABSTRACT  

HTLV-III Infection Among Health Care Workers: Association With Needle-Stick Injuries
Weiss et al.
JAMA 1985;254:2089-2093.
ABSTRACT  

Human T-Lymphotropic Retrovirus Type III / Lymphadenopathy-Associated Virus Antibody: Association With Hemophiliacs' Immune Status and Blood Component Usage
Jason et al.
JAMA 1985;253:3409-3415.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.